ATOS

Atossa Genetics Inc (ATOS)

US
$ 0.99-4.81%

Price Chart

Key Statistics

Market Cap
$ 85.69M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.46M
52W High
$ 1.81
52W Low
$ 0.55
Dividend Yield
0.00%
Beta
1.47

Technicals

50-Day MA
0.7196
200-Day MA
1.1222
52 Week High
1.81
52 Week Low
0.5526

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in .

Employees
15
Headquarters
Seattle, WA
CEO
Dr. Steven C. Quay FCAP, M.D., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg